Authored By: Sarah
05 Mar 2025

Cardiovascular and Soft Tissue Repair Patches Market Analysis 2024-2028

The cardiovascular and soft tissue repair patches market is expected to grow significantly, increasing by USD 1.99 billion at a CAGR of 8.09% between 2023 and 2028. This growth is driven by the rising incidence of myocardial infarctions (MIs) and advancements in diagnostic technologies. These patches are essential for repairing vascular and soft tissues, including dural and cardiovascular patches. The market is also fueled by the demand for minimally invasive surgeries and the shortage of skilled cardiac surgeons. Despite challenges such as high costs and potential complications, including infection and rejection, the market continues to expand due to the advantages these patches provide, such as reduced recovery time, minimal scarring, and improved patient outcomes.

Global cardiovascular and soft tissue repair patches market 2024-2028

For more details about the industry, get the PDF sample report for free

Market Segmentation

The report offers a detailed analysis of the cardiovascular and soft tissue repair patches market, with data segmented by application, raw material, and geography.

Application

  • Soft tissue repair
  • Cardiac repair
  • Vascular repair
  • Pericardial repair
  • Dural repair

Raw Material

  • ePTFE
  • Biomaterial and tissue-engineered material

Geography

  • North America
    • US
  • Europe
    • Germany
    • UK
  • Asia
    • China
    • Japan
  • Rest of the World (ROW)

By Application Insights

The soft tissue repair segment is expected to see significant growth, driven by the increasing prevalence of cardiovascular disorders, particularly those resulting from atherosclerosis. Atherosclerosis, caused by high cholesterol, leads to coronary artery disease and increases the need for cardiovascular and soft tissue repair patches. This segment has grown from USD 1.30 billion in 2018 and is expected to continue its upward trajectory during the forecast period.

Regional Insights

The North American market is expected to contribute 37% to global market growth. This expansion is attributed to the rising prevalence of myocardial infarction (MI) and the increasing number of elective surgeries. Risk factors such as obesity, diabetes, high blood pressure, and lifestyle factors contribute to the higher incidence of MI, further driving demand for cardiovascular and soft tissue repair patches. Additionally, reimbursement schemes for surgical procedures and advances in tissue engineering materials, like bionic heart patches, support market growth.

Market Dynamics

Market Driver: The rising incidence of myocardial infarction (MI) is a key driver. The increase in MI cases is linked to several factors such as obesity, diabetes, hypertension, sedentary lifestyles, smoking, and an aging population. As per the Centers for Disease Control and Prevention (CDC), nearly 47% of Americans have at least one risk factor for MI, leading to a high demand for treatment solutions, including cardiovascular and soft tissue repair patches.

Market Trends: Advancements in diagnostic technologies are a prominent trend. Improved imaging modalities like cardiac magnetic resonance imaging and computed tomography angiography allow for earlier and more accurate diagnoses of MI and cardiovascular issues, ultimately enhancing treatment outcomes.

Market Challenge: A shortage of skilled cardiac surgeons is a key challenge. While tissue repair patches provide an alternative to traditional surgeries, the lack of trained professionals in this field remains a barrier. These patches reduce the need for highly skilled surgeons, contributing to their growing demand.

Get more details by ordering the complete report

Key Players:

  • B.Braun SE
  • Aegis Lifesciences Pvt. Ltd.
  • Anteris Technologies Ltd.
  • Baxter International Inc.
  • Becton Dickinson and Co.
  • Braile Biomedica
  • CorMatrix Inc.
  • Edwards Lifesciences Corp.
  • Glycar SA
  • Integra Lifesciences Corp.
  • Labcor Laboratorios Ltda.
  • LeMaitre Vascular Inc.
  • Maverick Biosciences Pty Ltd.
  • Shockwave Medical Inc.
  • Tisgenx Inc.
  • Vascudyne Inc.
  • W. L. Gore and Associates Inc.
Read News Read Less
Interested in this report?
Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.